99
Participants
Start Date
October 12, 2023
Primary Completion Date
August 6, 2025
Study Completion Date
August 6, 2025
SAR447537
A1PI, Recombinant, Bivalent Fc Fusion Protein
Zemaira
Alpha1-Proteinase Inhibitor (Human)
NZRSI, Greenlane
Investigational Site Number : 403, Auckland
Donna McIntyre, Brisbane
Investigational Site Number : 701, Hellerup
Investigational Site Number : 203, Fitzroy
Eastern Health Clinical School, Box Hill
Frankston Hospital, Frankston
Investigational Site Number : 202, Chermside
Investigational Site Number : 201, Adelaide
Royal Adelaide Hospital, North Adelaide
Institute for Respiratory Health, Nedlands
Investigational Site Number : 206, Nedlands
Investigational Site Number : 404, Wellington
P3 Research, Wellington
Investigational Site Number : 702, Vejle
Columbia University Irving Medical Center- Site Number : 104, New York
Investigational Site Number : 903, Santiago de Compostela
Penn State Health Milton S. Hershey Medical Center, Hershey
Temple University Hospital- Site Number : 130, Philadelphia
Temple University Hospital, Philadelphia
Velocity Clinical Research - Spartanburg - PPDS, Spartanburg
University of Florida College of Medicine- Site Number : 101, Gainesville
University of Florida, Gainesville
University of Miami, Miami
Pulmonary and Sleep of Tampa Bay, Tampa
University of Alabama at Birmingham, Birmingham
Investigational Site Number : 901, Santander
Loyola University Medical Center- Site Number : 112, Maywood
Loyola University Medical Center, Maywood
Hannibal Clinic, Hannibal
Houston Methodist Hospital- Site Number : 113, Houston
Houston Methodist Hospital, Houston
National Jewish Medical and Research Center, Denver
University of Utah Health, Salt Lake City
David Geffen School of Medicine, Los Angeles
UC Davis Comprehensive Cancer Center- Site Number : 110, Sacramento
UC Davis Medical Center, Sacramento
Oregon Health and Science University- Site Number : 117, Portland
Oregon Health and Science University, Portland
University of Alabama at Birmingham- Site Number : 105, Birmingham
St Joseph's Hospital and Medical Center- Site Number : 126, Phoenix
St Joseph's Hospital and Medical Center, Phoenix
David Geffen School of Medicine- Site Number : 124, Los Angeles
National Jewish Medical and Research Center- Site Number : 123, Denver
Western Connecticut Medical Group, Danbury
Bruce W. Carter Miami VA Medical Center - NAVREF - PPDS- Site Number : 114, Miami
Pulmonary and Sleep of Tampa Bay- Site Number : 115, Tampa
Indiana University, Indianapolis
M Health Fairview Clinics and Surgery Center - Minneapolis- Site Number : 125, Minneapolis
M Health Fairview Clinics and Surgery Center - Minneapolis, Minneapolis
Hannibal Regional Healthcare System-HRMG-Hannibal- Site Number : 111, Hannibal
Clinical Research Associates Of Central PA , LLC- Site Number : 128, DuBois
Clinical Research Associates Of Central PA , LLC, DuBois
Penn State Health Milton S. Hershey Medical Center- Site Number : 122, Hershey
Velocity Clinical Research - Spartanburg - PPDS- Site Number : 120, Spartanburg
University of Utah Health Care- Site Number : 106, Salt Lake City
Queensland Centre for Pulmonary Transplantation, Chermside
St Vincent Hospital Melbourne, Fitzroy
Investigational Site Number : 801, Warsaw
Investigational Site Number : 802, Krakow
Investigational Site Number : 601, Gothenburg
Ninewells Hospital - PPDS, Dundee
Investigational Site Number : 306, Wythenshawe
Medicines Evaluation Unit, Manchester
Investigational Site Number : 302, Birmingham
Lead Sponsor
Sanofi
INDUSTRY